Ozempic-Style Drugs Linked to a Third Less Breast Cancer in a Large Study (opens in new tab)

Women taking GLP-1 drugs like Ozempic had roughly 30% lower odds of developing breast cancer, a study of more than 111,000 patients presented at the ASCO cancer meeting found. The finding is observational rather than proof, and the researchers have launched a trial to test whether the effect is real.